Cyprus vs Iraq: Hepatitis B surface antigen (HBsAg) prevalence
Cyprus
0.5%
in 2024
Iraq
0.4%
in 2024
Cyprus rank
59th
Iraq rank
62nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Cyprus
- Iraq
How they compare
Cyprus currently reports 0.5% against 0.4% in Iraq, a difference of 0.1%.
That makes Cyprus's figure about 1.2 times Iraq's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Iraq ahead.
Cyprus ranks 59th and Iraq ranks 62nd of 194 countries.
Iraq has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cyprus | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.6% | 0.8% | 0.2% | Iraq |
| 2020s | 0.5% | 0.5% | 0.0% | Iraq |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Cyprus or Iraq?
- Cyprus, at 0.5% against 0.4% in Iraq as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Cyprus and Iraq?
- 0.1%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Iraq?
- 10 years are reported by both, from 2015 to 2024.
- How do Cyprus and Iraq rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Cyprus ranks 59th and Iraq ranks 62nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.